Sandbox Azilsartan: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{CMG}} ===''Azilsartan Kamedoxomil''=== * Edarbi ===''Azilsartan Medoxomil/Chlorthalidone..." |
|||
| Line 12: | Line 12: | ||
==Overview== | ==Overview== | ||
Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist used in treatment of [[hypertension]] to lower blood pressure. Common adverse reactions include [[hypotension]]/[[orthostatic hypotension]]. | Azilsartan is a selective AT1 subtype [[angiotensin]] II receptor antagonist used in treatment of [[hypertension]] to lower blood pressure. Common adverse reactions include [[hypotension]]/[[orthostatic hypotension]]. | ||
==Category== | ==Category== | ||
Angiotensin 2 Receptor Blocker | Angiotensin 2 Receptor Blocker | ||
Latest revision as of 20:19, 31 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Azilsartan Kamedoxomil
Azilsartan Medoxomil/Chlorthalidone
Overview
Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist used in treatment of hypertension to lower blood pressure. Common adverse reactions include hypotension/orthostatic hypotension.
Category
Angiotensin 2 Receptor Blocker